Aislinn Antrim, Assistant Editor

The CDC is making strides toward better understanding the pneumonia-like coronavirus (2019-nCoV) that originated in Wuhan, China.

PTSD can have debilitating effects, including flashbacks, nightmares, and extreme anxiety.

Oprah Winfrey visited a pharmacy in Charlotte, North Carolina, during her 2020 Vision tour to raise awareness about mental and physical health.

Opioid agonist therapy (OAT) must be widely disseminated and increased in Ukraine in order to optimize HIV prevention and treatment goals, according to a recent study published in The Lancet.

A proposed FDA guidance could significantly impact veterinary practices and their ability to compound medicines for animal patients, according to a national survey.1

Valoctocogene roxaparvovec (Valrox, BioMarin Pharmaceutical Inc) would be the first gene therapy in the United States for the most common form of hemophilia if approved by the FDA.1

During a health care conference on Thursday, Republican Federal Trade Commissioner Christine Wilson expressed support for allowing Medicare to negotiate drug prices.1

A case of the virus that reportedly originated in Wuhan City, China has been confirmed in Washington State.

The findings support the inclusion of these patient populations in ICI-based clinical trials and treatment.

Hospitalization offers unique opportunities to engage out-of-care individuals with the ultimate goal of improving their HIV outcomes and reducing health disparities.

Avapritinib was awarded FDA approval on Jan 9.

Counties in Medicaid expansion states saw an 11% lower rate of heroin deaths and a 10% lower rate of deaths involving synthetic opioids compared with counties in non-expansion states.

Starting January 2020, aspiring certified pharmacy technicians must complete a Pharmacy Technician Certification Exam-recognized education or training program, or have equivalent work experience before taking the exam.

The statement pointed out that the spread of legalized marijuana products has increased the need for unified labeling requirements.

Pharmacy students at the University of North Carolina (UNC)-Chapel Hill Eshelman School of Pharmacy are attempting to understand why clinical research takes so long to impact patient care, as well as what they can do about it in their own practices.

The proposal, which is still largely conceptual, was a part of Newsom’s proposed 2020-2021 budget.1

Sunday was National Pharmacist Day, and we asked on Facebook why you entered the pharmacy field, and why you continue to believe in the importance of the profession.

A new study published in The American Journal of Emergency Medicine found that rapid correction of elevated serum potassium levels was associated with significant reduced mortality in patients admitted to the emergency department (ED) for hyperkalemia.

A key demand was for the Ohio Department of Medicaid (ODM) to set a minimum reimbursement level and dispensing fees for Managed Medicaid, in order to ensure that pharmacies receive adequate reimbursement plans.

By entering clinical and disease characteristics into a learning algorithm, researchers were able to create an efficacy prediction for CDK inhibitors.

The bill would have given the state's superintendent of insurance licensing and regulatory authority over pharmacy benefit managers (PBMs).1

In order to improve the efficacy of checkpoint blockade treatments in patients with breast cancer, it is necessary to consider treatment through the lens of the cancer immunity cycle.

The study results were presented at the 2019 San Antonio Breast Cancer Symposium, held December 10 through 14.

Despite the fact that menopausal hormone therapy with estrogen plus progestin is frequently used, its influence on breast cancer incidence and mortality has been debated, with discordant findings from prospective observational studies compared with randomized clinical trials.

Although there is no standard of care therapy following second-line treatment for human epidermal growth receptor 2 (HER2)-positive breast cancer, there are a number of options being researched.

By identifying molecular alterations contributing to CDK4/6i resistance, researchers hope to better understand which patients with breast cancer will respond best to the therapy.

Investigators have established a genomic outline of the CDK4/6i resistance in patients with breast cancer, growing the potential for novel treatments to circumvent that resistance.

The study results also show improved outcomes for patients with brain metastases.

Although CDK4/6 inhibitors prolong progression-free survival for patients with estrogen receptor-positive breast cancer, the ideal treatment for each patient is currently unclear until adverse effects appear.

The research presented at the 2019 San Antonio Breast Cancer Symposium suggests that the different mechanisms could be exploited to overcome CDK4/6 inhibitor resistance in breast cancer patients.